Incyte ($INCY) Insider Trading & Smart Money Activity

Incyte Corporation · Biotechnology · Latest filing Oct 14, 2026

Incyte Corporation ($INCY) has 5 13F position changes and 6 analyst ratings on file.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
0
Net insider $ (12 mo)
$0
Congress trades (12 mo)
0
13F moves on file
5
Analyst ratings on file
6

INCY insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 1 / 3
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 1

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All INCY insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
13F Fulton Bank, N.A. Reduced -11.26K sh $731.38K —
Analyst HC Wainwright Reiterates to Buy PT $152 Read
Analyst Stifel Reiterates to Buy PT $157 -2.4% —
Analyst HC Wainwright Reiterates to Buy PT $152 -8.6% —
Analyst HC Wainwright Reiterates to buy PT $140 +0.8%+10.8% Read
Analyst BMO Capital Raises to hold PT $94 +10.6%+11.7% Read
Analyst HC Wainwright Reiterates to buy PT $140 -3.4%+14.8% —
13F Avoro Capital Advisors Sold out -135K sh +1.9%+7.0% Read
13F Dodge & Cox Reduced -1.01M sh $1.40B -0.2%+4.5% —
13F Dodge & Cox Reduced -1.01M sh $1.31B -0.2%+4.5% Read
13F Robeco Institutional Asset Management B.V. Added +33.59K sh $288.30M +1.6%+1.2% —

1W / 1M / 6M = how INCY moved from the trade or filing date.

Institutions moving INCY (13F)

Analyst ratings on INCY

DateFirmActionRatingPrice target1W1M6MStory
HC Wainwright Reiterates Buy $152 Read
Stifel Reiterates Buy $145 → $157 -2.4% —
HC Wainwright Reiterates Buy $150 → $152 -8.6% —
HC Wainwright Reiterates buy $140 +0.8%+10.8% Read
BMO Capital Raises hold $94 +10.6%+11.7% Read
HC Wainwright Reiterates buy $140 -3.4%+14.8% —

Frequently asked questions

Which institutions changed their INCY positions?

Recent 13F filers moving the stock include Dodge & Cox, Fulton Bank, N.A., Avoro Capital Advisors and Robeco Institutional Asset Management B.V..

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text